Therapeutically targeting this neurotoxic feedforward loop—either by correcting the energy imbalance or mitigating stress response activation—may be a powerful approach to mitigate neurodegeneration in C9orf72-ALS/FTD. This evidence concerns the gene C9orf72 and frontotemporal dementia.